Log In
BCIQ
Print this Print this
 

SRA141 (formerly AS-141)

  Manage Alerts
Collapse Summary General Information
Company Carna Biosciences Inc.
DescriptionSmall molecule inhibitor of cell division cycle 7-related protein kinase (CDC7)
Molecular Target Cell division cycle 7-related protein kinase (CDC7)
Mechanism of ActionCDC7 protein kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerSierra Oncology Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$270.9M

$0.9M

$270.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/26/2016

$270.9M

$0.9M

$270.0M

Get a free BioCentury trial today